{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T18:23:22Z","timestamp":1775499802597,"version":"3.50.1"},"reference-count":111,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2011,3,30]],"date-time":"2011-03-30T00:00:00Z","timestamp":1301443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis Care &amp; Research"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1002\/acr.20460","type":"journal-article","created":{"date-parts":[[2011,3,30]],"date-time":"2011-03-30T13:08:46Z","timestamp":1301490526000},"page":"465-482","source":"Crossref","is-referenced-by-count":662,"title":["2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features"],"prefix":"10.1002","volume":"63","author":[{"given":"Timothy","family":"Beukelman","sequence":"first","affiliation":[]},{"given":"Nivedita M.","family":"Patkar","sequence":"additional","affiliation":[]},{"given":"Kenneth G.","family":"Saag","sequence":"additional","affiliation":[]},{"given":"Sue","family":"Tolleson\u2010Rinehart","sequence":"additional","affiliation":[]},{"given":"Randy Q.","family":"Cron","sequence":"additional","affiliation":[]},{"given":"Esi Morgan","family":"DeWitt","sequence":"additional","affiliation":[]},{"given":"Norman T.","family":"Ilowite","sequence":"additional","affiliation":[]},{"given":"Yukiko","family":"Kimura","sequence":"additional","affiliation":[]},{"given":"Ronald M.","family":"Laxer","sequence":"additional","affiliation":[]},{"given":"Daniel J.","family":"Lovell","sequence":"additional","affiliation":[]},{"given":"Alberto","family":"Martini","sequence":"additional","affiliation":[]},{"given":"C. Egla","family":"Rabinovich","sequence":"additional","affiliation":[]},{"given":"Nicolino","family":"Ruperto","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2011,3,30]]},"reference":[{"key":"e_1_2_8_2_2","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty RE","year":"2004","journal-title":"J Rheumatol"},{"key":"e_1_2_8_3_2","first-page":"367","article-title":"Juvenile arthritis: who gets it, where and when? A review of current data on incidence and prevalence","volume":"17","author":"Andersson Gare B","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_8_4_2","first-page":"499","article-title":"Epidemiology of rheumatoid arthritis, juvenile idiopathic arthritis and gout in two regions of the Czech Republic in a descriptive population\u2010based survey in 2002\u20102003","volume":"24","author":"Hanova P","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_8_5_2","first-page":"1382","article-title":"Radiographic and clinical outcome in early juvenile rheumatoid arthritis and juvenile spondyloarthropathy: a 3\u2010year prospective study","volume":"33","author":"Selvaag AM","year":"2006","journal-title":"J Rheumatol"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10783"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.2.198"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10444"},{"key":"e_1_2_8_9_2","first-page":"394","article-title":"Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis","volume":"30","author":"Bowyer SL","year":"2003","journal-title":"J Rheumatol"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.12.1428"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200003163421103"},{"key":"e_1_2_8_12_2","first-page":"2055","article-title":"Prolonged efficacy of etanercept in refractory enthesitis\u2010related arthritis","volume":"31","author":"Henrickson M","year":"2004","journal-title":"J Rheumatol"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.014886"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20793"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.23427"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706290"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050473"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60998-8"},{"key":"e_1_2_8_19_2","volume-title":"The RAND\/UCLA Appropriateness Method user's manual","author":"Fitch K","year":"2000"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.23721"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20295"},{"key":"e_1_2_8_22_2","unstructured":"The AGREE Collaboration. Appraisal of Guidelines for Research and Education (AGREE) instrument. St. George's Hospital Medical School.2001. URL:www.agreecollaboration.org."},{"key":"e_1_2_8_23_2","first-page":"291","volume-title":"Textbook of pediatric rheumatology","author":"Cassidy JT","year":"2005"},{"key":"e_1_2_8_24_2","first-page":"386","article-title":"Prognostic factors in juvenile rheumatoid arthritis: a case\u2010control study revealing early predictors and outcome after 14.9 years","volume":"30","author":"Flato B","year":"2003","journal-title":"J Rheumatol"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10146"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22181"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10544"},{"key":"e_1_2_8_28_2","first-page":"295","article-title":"The natural history of juvenile chronic arthritis: a population based cohort study. I. Onset and disease process","volume":"22","author":"Gare BA","year":"1995","journal-title":"J Rheumatol"},{"key":"e_1_2_8_29_2","first-page":"952","article-title":"Long\u2010term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. II. Early predictors of outcome","volume":"24","author":"Ruperto N","year":"1997","journal-title":"J Rheumatol"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200008)43:8<1858::AID-ANR23>3.0.CO;2-A"},{"key":"e_1_2_8_31_2","first-page":"366","article-title":"Outcome and predictive factors in juvenile rheumatoid arthritis and juvenile spondyloarthropathy","volume":"25","author":"Flato B","year":"1998","journal-title":"J Rheumatol"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.11337"},{"key":"e_1_2_8_33_2","first-page":"308","article-title":"The natural history of juvenile chronic arthritis: a population based cohort study. II. Outcome","volume":"22","author":"Gare BA","year":"1995","journal-title":"J Rheumatol"},{"key":"e_1_2_8_34_2","first-page":"492","article-title":"Measurement of biomarkers in juvenile idiopathic arthritis patients and their significant association with disease severity: a comparative study","volume":"26","author":"Gilliam BE","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1080\/08820130802438057"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)80427-5"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200011)43:11<2402::AID-ANR5>3.0.CO;2-C"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21774"},{"key":"e_1_2_8_39_2","first-page":"211","article-title":"Systemic onset juvenile chronic arthritis, polyarticular pattern and hip involvement as markers for a bad prognosis","volume":"19","author":"Modesto C","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.24516"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20288"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20860"},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22838"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.23916"},{"key":"e_1_2_8_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20221"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22070"},{"key":"e_1_2_8_47_2","unstructured":"Oxford Centre for Evidence Based Medicine. Levels of evidence.2009. URL:http:\/\/www.cebm.net\/index.aspx?o=1025."},{"key":"e_1_2_8_48_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.126532"},{"key":"e_1_2_8_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199911)42:11<2330::AID-ANR11>3.0.CO;2-B"},{"key":"e_1_2_8_50_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-007-0525-9"},{"key":"e_1_2_8_51_2","first-page":"2330","article-title":"Benefit of intraarticular corticosteroid injection under fluoroscopic guidance for subtalar arthritis in juvenile idiopathic arthritis","volume":"33","author":"Beukelman T","year":"2006","journal-title":"J Rheumatol"},{"key":"e_1_2_8_52_2","first-page":"2507","article-title":"Comparison of the intraarticular effectiveness of triamcinolone hexacetonide and triamcinolone acetonide in treatment of juvenile rheumatoid arthritis","volume":"31","author":"Eberhard BA","year":"2004","journal-title":"J Rheumatol"},{"key":"e_1_2_8_53_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh313"},{"key":"e_1_2_8_54_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg358"},{"key":"e_1_2_8_55_2","first-page":"719","article-title":"Treatment of juvenile idiopathic arthritis with intra\u2010articular triamcinolone hexacetonide: evaluation of clinical effectiveness correlated with circulating ANA and T \u03b3\/\u03b4 + and B CD5+ lymphocyte populations of synovial fluid","volume":"20","author":"Lepore L","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_8_56_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10313"},{"key":"e_1_2_8_57_2","first-page":"2100","article-title":"Factors affecting the efficacy of intraarticular corticosteroid injection of knees in juvenile idiopathic arthritis","volume":"28","author":"Ravelli A","year":"2001","journal-title":"J Rheumatol"},{"key":"e_1_2_8_58_2","first-page":"2696","article-title":"A subgroup\u2010specific evaluation of the efficacy of intraarticular triamcinolone hexacetonide in juvenile chronic arthritis","volume":"27","author":"Breit W","year":"2000","journal-title":"J Rheumatol"},{"key":"e_1_2_8_59_2","first-page":"182","article-title":"Intraarticular triamcinolone hexacetonide injection in children with chronic arthritis: a survey of clinical practice","volume":"40","author":"Yang MH","year":"1999","journal-title":"Acta Paediatr Taiwan"},{"key":"e_1_2_8_60_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199807)41:7<1210::AID-ART10>3.0.CO;2-5"},{"key":"e_1_2_8_61_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/36.11.1214"},{"key":"e_1_2_8_62_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02012732"},{"key":"e_1_2_8_63_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1993.tb12815.x"},{"key":"e_1_2_8_64_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01963559"},{"key":"e_1_2_8_65_2","first-page":"153","article-title":"Triamcinolone into the knee joint in juvenile chronic arthritis","volume":"6","author":"Earley A","year":"1988","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_8_66_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780290808"},{"key":"e_1_2_8_67_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.24190"},{"key":"e_1_2_8_68_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.087593"},{"key":"e_1_2_8_69_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W"},{"key":"e_1_2_8_70_2","unstructured":"Infliximab[package insert]. Malvern (PA): Centocor Ortho Biotech;2010."},{"key":"e_1_2_8_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)80708-5"},{"key":"e_1_2_8_72_2","first-page":"724","article-title":"Double\u2010blind study of sulindac and aspirin in juvenile chronic arthritis","volume":"70","author":"Bhettay E","year":"1986","journal-title":"S Afr Med J"},{"key":"e_1_2_8_73_2","doi-asserted-by":"publisher","DOI":"10.3109\/03009748409111307"},{"key":"e_1_2_8_74_2","doi-asserted-by":"publisher","DOI":"10.3109\/03009748309099735"},{"key":"e_1_2_8_75_2","first-page":"123","article-title":"Aspirin and fenoprofen (Nalfon) in the treatment of juvenile rheumatoid arthritis results of the double blind\u2010trial: a segment II study","volume":"9","author":"Brewer EJ","year":"1982","journal-title":"J Rheumatol"},{"key":"e_1_2_8_76_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.38.2.152"},{"key":"e_1_2_8_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(77)81045-7"},{"key":"e_1_2_8_78_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041810"},{"key":"e_1_2_8_79_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200008)43:8<1849::AID-ANR22>3.0.CO;2-F"},{"key":"e_1_2_8_80_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199204163261602"},{"key":"e_1_2_8_81_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.24087"},{"key":"e_1_2_8_82_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-005-1116-7"},{"key":"e_1_2_8_83_2","first-page":"179","article-title":"The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate","volume":"31","author":"Alsufyani K","year":"2004","journal-title":"J Rheumatol"},{"key":"e_1_2_8_84_2","first-page":"623","article-title":"Efficacy and safety of methotrexate therapy for juvenile rheumatoid arthritis","volume":"99","author":"Lin YT","year":"2000","journal-title":"J Formos Med Assoc"},{"key":"e_1_2_8_85_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199805)41:5<808::AID-ART6>3.0.CO;2-T"},{"key":"e_1_2_8_86_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21121"},{"key":"e_1_2_8_87_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198605153142001"},{"key":"e_1_2_8_88_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.064717"},{"key":"e_1_2_8_89_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.087411"},{"key":"e_1_2_8_90_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.087130"},{"key":"e_1_2_8_91_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22025"},{"key":"e_1_2_8_92_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21778"},{"key":"e_1_2_8_93_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032534"},{"key":"e_1_2_8_94_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-003-0378-0"},{"key":"e_1_2_8_95_2","doi-asserted-by":"publisher","DOI":"10.3310\/hta11280"},{"key":"e_1_2_8_96_2","first-page":"545","article-title":"Use of infliximab in patients with systemic juvenile idiopathic arthritis refractory to etanercept","volume":"23","author":"Katsicas MM","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_8_97_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10885"},{"key":"e_1_2_8_98_2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090952"},{"key":"e_1_2_8_99_2","first-page":"935","article-title":"Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis","volume":"32","author":"Kimura Y","year":"2005","journal-title":"J Rheumatol"},{"key":"e_1_2_8_100_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-005-0138-5"},{"key":"e_1_2_8_101_2","doi-asserted-by":"publisher","DOI":"10.3109\/03009749609082663"},{"key":"e_1_2_8_102_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.23437"},{"key":"e_1_2_8_103_2","first-page":"2071","article-title":"Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis","volume":"31","author":"Verbsky JW","year":"2004","journal-title":"J Rheumatol"},{"key":"e_1_2_8_104_2","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3181a4f459"},{"key":"e_1_2_8_105_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-008-0995-9"},{"key":"e_1_2_8_106_2","first-page":"599","article-title":"Cyclosporine A in juvenile idiopathic arthritis: results of the PRCSG\/PRINTO phase IV post marketing surveillance study","volume":"24","author":"Ruperto N","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_8_107_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/40.8.907"},{"key":"e_1_2_8_108_2","first-page":"2501","article-title":"Guidelines for blood test monitoring of methotrexate toxicity in juvenile idiopathic arthritis","volume":"31","author":"Ortiz\u2010Alvarez O","year":"2004","journal-title":"J Rheumatol"},{"key":"e_1_2_8_109_2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090482"},{"key":"e_1_2_8_110_2","first-page":"2442","article-title":"Hepatotoxicity in patients with juvenile idiopathic arthritis receiving long\u2010term methotrexate therapy","volume":"29","author":"Lahdenne P","year":"2002","journal-title":"J Rheumatol"},{"key":"e_1_2_8_111_2","doi-asserted-by":"publisher","DOI":"10.1002\/anr.1780320604"},{"key":"e_1_2_8_112_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21043"}],"container-title":["Arthritis Care &amp; Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Facr.20460","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acr.20460","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T14:39:14Z","timestamp":1759415954000},"score":1,"resource":{"primary":{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/10.1002\/acr.20460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,30]]},"references-count":111,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["10.1002\/acr.20460"],"URL":"https:\/\/doi.org\/10.1002\/acr.20460","archive":["Portico"],"relation":{},"ISSN":["2151-464X","2151-4658"],"issn-type":[{"value":"2151-464X","type":"print"},{"value":"2151-4658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,30]]}}}